Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.Dismiss Notice
Biogen's success of experimental Alzheimer’s drug
Discussion in 'Pharma/Biotech Comp - Gen Discussion |Pharma Sales' started by RobertPhillips900, Jul 6, 2018 at 12:07 PM.